Simeprevir (Portuguese Wikipedia)
Analysis of information sources in references of the Wikipedia article "Simeprevir" in Portuguese language version.
refsWebsite
Global rank
Portuguese rank
1st place
1st place
102nd place
459th place
low place
low place
3rd place
6th place
5th place
5th place
books.google.com
- Grubbs, Robert H.; O'Leary, Daniel J. (2015). Handbook of Metathesis, Volume 2: Applications in Organic Synthesis (em inglês). [S.l.]: John Wiley & Sons. p. 699. ISBN 9783527694020
doi.org
dx.doi.org
- Majumdar, A; Kitson, MT; Roberts, SK (junho de 2016). «Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis.». Alimentary Pharmacology & Therapeutics. 43 (12): 1276–92. PMID 27087015. doi:10.1111/apt.13633
- Brochot, E; Helle, F; François, C; Castelain, S; Capron, D; Nguyen-Khac, E; Duverlie, G (abril de 2015). «Which therapeutic option for hepatitis C virus genotype 1?». Scandinavian Journal of Gastroenterology. 50 (4): 470–8. PMID 25396710. doi:10.3109/00365521.2014.978364
- Dugum M, O'Shea R (2014). «Hepatitis C virus: Here comes all-oral treatment». Cleveland Clinic Journal of Medicine. 81 (3): 159–72. PMID 24591471. doi:10.3949/ccjm.81a.13155
drugs.com
- «Simeprevir». The American Society of Health-System Pharmacists. Consultado em 30 de novembro de 2016. Cópia arquivada em 1 de dezembro de 2016
handle.net
hdl.handle.net
- World Health Organization (2019). Executive summary: the selection and use of essential medicines 2019: report of the 22nd WHO Expert Committee on the selection and use of essential medicines. Geneva: World Health Organization. hdl:10665/325773
. WHO/MVP/EMP/IAU/2019.05. License: CC BY-NC-SA 3.0 IGO - World Health Organization (2019). The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2019 (including the 21st WHO Model List of Essential Medicines and the 7th WHO Model List of Essential Medicines for Children). Geneva: World Health Organization. ISBN 9789241210300. ISSN 0512-3054. hdl:10665/330668. WHO technical report series;1021
hcvguidelines.org
- «Initial treatment of HCV infection». www.hcvguidelines.org. Outubro de 2016. Consultado em 1 de dezembro de 2016. Cópia arquivada em 7 de dezembro de 2016
nih.gov
ncbi.nlm.nih.gov
- Majumdar, A; Kitson, MT; Roberts, SK (junho de 2016). «Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis.». Alimentary Pharmacology & Therapeutics. 43 (12): 1276–92. PMID 27087015. doi:10.1111/apt.13633
- Brochot, E; Helle, F; François, C; Castelain, S; Capron, D; Nguyen-Khac, E; Duverlie, G (abril de 2015). «Which therapeutic option for hepatitis C virus genotype 1?». Scandinavian Journal of Gastroenterology. 50 (4): 470–8. PMID 25396710. doi:10.3109/00365521.2014.978364
- Dugum M, O'Shea R (2014). «Hepatitis C virus: Here comes all-oral treatment». Cleveland Clinic Journal of Medicine. 81 (3): 159–72. PMID 24591471. doi:10.3949/ccjm.81a.13155
web.archive.org
- «Simeprevir». The American Society of Health-System Pharmacists. Consultado em 30 de novembro de 2016. Cópia arquivada em 1 de dezembro de 2016
- «Initial treatment of HCV infection». www.hcvguidelines.org. Outubro de 2016. Consultado em 1 de dezembro de 2016. Cópia arquivada em 7 de dezembro de 2016
worldcat.org
- World Health Organization (2019). The selection and use of essential medicines: report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2019 (including the 21st WHO Model List of Essential Medicines and the 7th WHO Model List of Essential Medicines for Children). Geneva: World Health Organization. ISBN 9789241210300. ISSN 0512-3054. hdl:10665/330668. WHO technical report series;1021